A systematic approach to improving medication safety in a pediatric intensive care unit

Related Experiment Video

Updated: May 26, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Chris J Dickinson1, Deborah S Wagner, Brenda E Shaw

  • 1Department of Pediatrics, University of Michigan Hospitals, MI, USA. chrisjd@umich.edu

Critical Care Nursing Quarterly
|December 14, 2011
PubMed

Insights

Improving pediatric medication safety is crucial in children's hospitals. Strategies include governance, standardization, pharmacy technicians, and enhancing safety culture in pediatric intensive care units.

Area of Science:

  • Pediatric Healthcare
  • Medication Safety
  • Quality Improvement

Background:

  • Children's hospitals face significant safety and quality challenges.
  • Pediatric medication safety is complex due to wide dose ranges and size variations, especially in pediatric intensive care units (PICUs).

Purpose of the Study:

  • To review literature and institutional experience on improving pediatric medication safety.
  • To identify key areas for enhancing medication safety in pediatric settings.

Main Methods:

  • Literature review.
  • Analysis of experiences at CS Mott Children's Hospital, University of Michigan.
  • Identification of critical issues in pediatric medication safety.

Main Results:

  • An effective pediatric medication safety governance structure is essential.
  • Standardizing practices for physicians, nurses, and pharmacists improves safety.
  • Utilizing pharmacy technicians as unit medication managers reduces costs and nursing workload.
  • Enhancing safety culture in the PICU is vital.

Conclusions:

  • A multi-faceted approach is necessary for robust pediatric medication safety.
  • Key interventions include governance, standardization, optimized staffing, and a strong safety culture.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...